Skip to main content

Sublocade News (Page 2)

FDA Medwatch Alert: Opioid Pain Relievers or Medicines to Treat Opioid Use Disorder - FDA Recommends Health Care Professionals Discuss Naloxone with All Patients when Prescribing

ISSUE: FDA is requiring drug manufacturers for all opioid pain relievers and medicines to treat opioid use disorder (OUD) to add new recommendations about naloxone to the prescribing information....

FDA Approves Sublocade (buprenorphine) Once-Monthly Injection for Opioid Use Disorder

November 30, 2017 – The U.S. Food and Drug Administration today approved Sublocade, the first once-monthly injectable buprenorphine product for the treatment of moderate-to-severe opioid use...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Opiate Dependence - Maintenance, Opiate Dependence

Sublocade patient information at Drugs.com